TORCH Infections in Pregnancy

Medically reviewed | Published: | Evidence level: 1A
New attention on maternal-fetal TORCH infections highlights a long-standing clinical challenge: infections that may cause few symptoms in pregnancy can still affect fetal development. CDC data show congenital cytomegalovirus alone affects about 1 in 200 babies in the United States, with about 1 in 5 of those children developing long-term health problems.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Infectious Disease

Quick Facts

TORCH Scope
5 infection groups
Congenital CMV
1 in 200 births
CMV Outcomes
About 1 in 5

What Are TORCH Infections in Pregnancy?

Quick answer: TORCH infections are a group of maternal infections that can cross or affect the placenta and cause congenital disease in the fetus or newborn.

TORCH is a clinical acronym for toxoplasmosis, other infections, rubella, cytomegalovirus and herpes simplex virus. The “other” category can include infections such as syphilis, varicella-zoster, parvovirus B19, HIV and hepatitis viruses, depending on the clinical context and local testing protocols. These infections matter because maternal illness can be mild, nonspecific or absent while fetal exposure may lead to miscarriage, stillbirth, growth restriction, brain injury, eye disease, hearing loss or neonatal infection.

Cytomegalovirus is a major example. The CDC describes congenital CMV as the most common infectious cause of birth defects in the United States, and many infected newborns look healthy at birth. Some later develop hearing loss or developmental problems, which is why TORCH discussions increasingly emphasize not only diagnosis at delivery but prevention, prenatal counseling and follow-up after birth.

Why Can Mild Maternal Infection Harm the Fetus?

Quick answer: Fetal risk depends on the pathogen, timing of infection, placental transmission and the developing organ systems exposed.

The maternal-fetal interface is designed to protect pregnancy while allowing nutrients, oxygen and immune signals to pass between mother and fetus. Some pathogens can evade these defenses, infect placental cells or trigger inflammatory responses that disrupt fetal growth. Earlier infection may be more damaging for organ formation, while later infection can sometimes carry a higher chance of transmission but different clinical consequences.

The pattern varies by infection. Rubella infection early in pregnancy can cause congenital rubella syndrome, but vaccination before pregnancy has made this preventable in many countries. Toxoplasmosis risk is linked to food and environmental exposure, including undercooked meat and contaminated soil. Syphilis can often be detected and treated during pregnancy, making timely prenatal screening one of the clearest prevention opportunities.

How Can Pregnant Patients Reduce TORCH Infection Risk?

Quick answer: Risk reduction depends on pre-pregnancy vaccination, prenatal screening, safer food practices, hygiene and prompt evaluation of concerning symptoms or exposures.

Prevention begins before pregnancy when possible. Rubella and varicella immunity should be reviewed because live vaccines are not given during pregnancy. During pregnancy, clinicians commonly screen for infections such as syphilis, HIV and hepatitis B, while additional testing for CMV, toxoplasmosis, parvovirus B19 or herpes may be guided by symptoms, ultrasound findings, exposure history or local guidelines.

Practical steps include washing hands after contact with young children’s saliva or diapers to reduce CMV exposure, avoiding undercooked meat, washing produce, using gloves for gardening or cat litter handling, and seeking care for genital lesions, fever, rash, swollen lymph nodes or known infectious exposures. The goal is not broad anxiety or indiscriminate testing, but targeted prevention and early diagnosis when results can change pregnancy or newborn care.

Frequently Asked Questions

Not usually. Broad TORCH panels can produce confusing results, so testing is often targeted to symptoms, exposure history, abnormal fetal ultrasound findings or specific prenatal screening recommendations.

Some can. Syphilis, HIV, hepatitis B prevention strategies and selected herpes management can reduce fetal or newborn risk, while treatment options for infections such as CMV and toxoplasmosis depend on timing, diagnosis and specialist guidance.

No. Many newborns with congenital CMV appear healthy at birth, but some later develop hearing loss or developmental problems, which is why follow-up matters when infection is suspected or confirmed.

References

  1. CDC. About Cytomegalovirus and Congenital CMV. https://www.cdc.gov/cytomegalovirus/about/index.html
  2. CDC. CMV and Congenital CMV: Babies Born with CMV. https://www.cdc.gov/cytomegalovirus/congenital-infection/index.html
  3. Megli CJ, Coyne CB. Infections at the maternal-fetal interface: an overview of pathogenesis and defence. Nature Reviews Microbiology. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8386341/
  4. American College of Obstetricians and Gynecologists. Practice Bulletin No. 151: Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy. Obstetrics & Gynecology. 2015.